(Q44820313)

English

Effects of memantine on cognition in patients with moderate to severe Alzheimer's disease: post-hoc analyses of ADAS-cog and SIB total and single-item scores from six randomized, double-blind, placebo-controlled studies

scientific article published in May 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Effects of memantine on cognition in patients with moderate to severe Alzheimer's disease: post-hoc analyses of ADAS-cog and SIB total and single-item scores from six randomized, double-blind, placebo-controlled studies (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Alzheimer's disease

0 references

1 reference

based on heuristic

inferred from title

Patrizia Mecocci

object named as

Patrizia Mecocci

1

0 references

author name string

Anna Bladström

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Karina Stender

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

language of work or name

0 references

publication date

1 May 2009

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

International Journal of Geriatric Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

532-538

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

The course of psychopathologic features in mild to moderate Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2226

21 January 2018

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2226

21 January 2018

Severe impairment battery. A neuropsychological test for severely demented patients.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2226

21 January 2018

A new rating scale for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2226

21 January 2018

Memantine treatment in patients with mild to moderate Alzheimer's disease: results of a randomised, double-blind, placebo-controlled 6-month study.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2226

7 January 2021

based on heuristic

inferred from DOI database lookup

Forecasting the global burden of Alzheimer’s disease

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2226

7 January 2021

based on heuristic

inferred from DOI database lookup

Memantine (Ebixa) in clinical practice - results of an observational study.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2226

7 January 2021

based on heuristic

inferred from DOI database lookup

Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2226

7 January 2021

based on heuristic

inferred from DOI database lookup

Do subgroups of patients with Alzheimer's disease exhibit asymmetric deficits on memory tests?

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2226

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis of six-month memantine trials in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2226

7 January 2021

based on heuristic

inferred from DOI database lookup

The Alzheimer's Disease Assessment Scale: evaluation of psychometric properties and patterns of cognitive decline in multicenter clinical trials of mild to moderate Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2226

7 January 2021

based on heuristic

inferred from DOI database lookup

Activities of daily living in moderate-to-severe Alzheimer disease: an analysis of the treatment effects of memantine in patients receiving stable donepezil treatment.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2226

7 January 2021

based on heuristic

inferred from DOI database lookup

Glutamatergic approaches to the treatment of cognitive and behavioural symptoms of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2226

7 January 2021

based on heuristic

inferred from DOI database lookup

Alzheimer's disease in real life--the dementia carer's survey

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2226

7 January 2021

based on heuristic

inferred from DOI database lookup

Psychopathological features in Alzheimer's disease: course and relationship with cognitive status.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2226

7 January 2021

based on heuristic

inferred from DOI database lookup

Criteria for the clinical diagnosis of Alzheimer's disease. Excerpts from the NINCDS-ADRDA Work Group report

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2226

7 January 2021

based on heuristic

inferred from DOI database lookup

Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical data

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2226

7 January 2021

based on heuristic

inferred from DOI database lookup

Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system--too little activation is bad, too much is even worse

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2226

7 January 2021

based on heuristic

inferred from DOI database lookup

Factorial validation of the Severe Impairment Battery for patients with Alzheimer's disease. A pilot study.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2226

7 January 2021

based on heuristic

inferred from DOI database lookup

Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2226

7 January 2021

based on heuristic

inferred from DOI database lookup

Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2226

7 January 2021

based on heuristic

inferred from DOI database lookup

Memantine in moderate-to-severe Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2226

7 January 2021

based on heuristic

inferred from DOI database lookup

Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2226

7 January 2021

based on heuristic

inferred from DOI database lookup

A 24-week randomized, controlled trial of memantine in patients with moderate-to-severe Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2226

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of the effect of memantine in reducing the worsening of clinical symptoms in patients with moderate to severe Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2226

7 January 2021

based on heuristic

inferred from DOI database lookup

Memantine in moderate to severe Alzheimer's disease: a meta-analysis of randomised clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2226

7 January 2021

based on heuristic

inferred from DOI database lookup

Memantine in severe dementia: results of the 9M-Best Study (Benefit and efficacy in severely demented patients during treatment with memantine).

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2226

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/GPS.2226

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44820313&oldid=2047848018"